Safety and Dose-Finding Study of Activated Protein C (Drotrecogin Alfa Activated) as an Anticoagulant in End-Stage Renal Disease Patients Treated with Hemodialysis

Publisher： Karger

E-ISSN： 1421-9735|37|3|243-248

ISSN： 0253-5068

Source： Blood Purification, Vol.37, Iss.3, 2014-06, pp. : 243-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis

By  

Nephron, Vol. 133, Iss. 3, 2016-06 ,pp. : 169-174

Karger

Access to resources Recommend Favorite

Raynaud’s Phenomenon and Endothelial Dysfunction in End-Stage Renal Disease Patients Treated with Hemodialysis

By  

Kidney and Blood Pressure Research, Vol. 28, Iss. 1, 2005-01 ,pp. : 27-31

Karger

Access to resources Recommend Favorite

Neurohumoral Activity, Heart Failure and Prognosis in Patients with End-Stage Renal Disease Treated by Hemodialysis

By  

Kidney and Blood Pressure Research, Vol. 30, Iss. 5, 2007-09 ,pp. : 347-357

Karger

Access to resources Recommend Favorite

Effects of Hemodialysis on Circulating Adrenomedullin Concentrations in Patients with End-Stage Renal Disease

By  

Blood Purification, Vol. 16, Iss. 5, 1999-01 ,pp. : 269-274

Karger

Access to resources Recommend Favorite

Effect of Missed Hemodialysis Treatments on Mortality in Patients with End-Stage Renal Disease

By  

Nephron, Vol. 79, Iss. 3, 1998-06 ,pp. : 385-386

Karger

Access to resources Recommend Favorite